WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential, including the three shown above: (left to right) chikungunya, dengue and parainfluenza viruses. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years. (Images: (from left) Cynthia Goldsmith, James Comer, Barbara Johnson, CDC; CDC and NIAID; Erskine Palmer, CDC)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
